Compare ARK Genomic Revolution ETF (ARKG) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs JetBlue Airways Corporation — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while JetBlue Airways Corporation trades at $5.72 (market cap $2.14B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals.
| ARKG | JBLU | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $6.46 |
52-Week Low | $23.09 | $4.03 |
Market Cap | — | $2.14B |
Enterprise Value | — | $9.31B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
JetBlue (JBLU) trades at $5.76, down 2.7% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported a net loss of $602 million in 2025, with negative profit margins and elevated debt levels. Recent news highlights a major Fort Lauderdale expansion, while analyst consensus is predominantly Hold with a $5.12 price target below the current price.
The outlook remains challenging due to persistent losses and high leverage, though expansion efforts and potential fuel cost relief offer some upside. Key risks include volatile oil prices, competitive pressure, and execution of the turnaround strategy. Investors should weigh cost management improvements against fundamental weaknesses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
